BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23819487)

  • 1. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review.
    Echouffo-Tcheugui JB; Ali MK; Roglic G; Hayward RA; Narayan KM
    Diabet Med; 2013 Nov; 30(11):1272-92. PubMed ID: 23819487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
    Groeneveld Y; Tavenier D; Blom JW; Polak BCP
    Diabet Med; 2019 Oct; 36(10):1199-1208. PubMed ID: 30677170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
    Younis N; Broadbent DM; Vora JP; Harding SP;
    Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
    Younis N; Broadbent DM; Harding SP; Vora JP
    Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active prevention in diabetic eye disease. A 4-year follow-up.
    Kristinsson JK; Hauksdóttir H; Stefánsson E; Jónasson F; Gíslason I
    Acta Ophthalmol Scand; 1997 Jun; 75(3):249-54. PubMed ID: 9253967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy screening: a systematic review of the economic evidence.
    Jones S; Edwards RT
    Diabet Med; 2010 Mar; 27(3):249-56. PubMed ID: 20536486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sight-threatening diabetic retinopathy at presentation to screening services in Fiji.
    Damato EM; Murray N; Szetu J; Sikivou BT; Emma S; McGhee CN
    Ophthalmic Epidemiol; 2014 Oct; 21(5):318-26. PubMed ID: 25157913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering the risk of visual impairment and blindness.
    Cunha-Vaz J
    Diabet Med; 1998; 15 Suppl 4():S47-50. PubMed ID: 9868992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
    Scanlon PH; Stratton IM; Bachmann MO; Jones C; Leese GP;
    Diabet Med; 2016 Dec; 33(12):1655-1658. PubMed ID: 27646856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of screening policies for diabetic retinopathy using simulation.
    Davies R; Roderick P; Canning C; Brailsford S
    Diabet Med; 2002 Sep; 19(9):762-70. PubMed ID: 12207814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy.
    Agardh E; Agardh CD; Hansson-Lundblad C
    Diabet Med; 1993 Jul; 10(6):555-9. PubMed ID: 8365093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of diabetic retinopathy at first presentation to the retinal screening service in the greater Wellington region of New Zealand 2006-2015, and implications for models of retinal screening.
    Chang LY; Lee AC; Sue W
    N Z Med J; 2017 Feb; 130(1450):78-88. PubMed ID: 28207727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
    Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP;
    Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes-related eye disorders.
    Sanders RJ; Wilson MR
    J Natl Med Assoc; 1993 Feb; 85(2):104-8. PubMed ID: 8441184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model.
    Bachmann MO; Nelson SJ
    J Epidemiol Community Health; 1998 Jan; 52(1):45-52. PubMed ID: 9604041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.
    Taylor-Phillips S; Mistry H; Leslie R; Todkill D; Tsertsvadze A; Connock M; Clarke A
    Br J Ophthalmol; 2016 Jan; 100(1):105-14. PubMed ID: 25586713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.
    Estil S; Steinarsson AÞ; Einarsson S; Aspelund T; Stefánsson E
    Acta Ophthalmol; 2020 Jun; 98(4):343-346. PubMed ID: 32216034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme.
    Younis N; Broadbent DM; Harding SP; Vora JR
    Diabet Med; 2002 Dec; 19(12):1014-21. PubMed ID: 12647843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini Review: Changes in the Incidence of and Progression to Proliferative and Sight-Threatening Diabetic Retinopathy Over the Last 30 Years.
    Liew G; Wong VW; Ho IV
    Ophthalmic Epidemiol; 2017 Apr; 24(2):73-80. PubMed ID: 28102748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.